Legato Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302K | Hold |
1,747
| – | – | 0.04% | 497 |
|
|
2025
Q1 | $272K | Sell |
1,747
-174
| -9% | -$27.1K | 0.04% | 498 |
|
|
2024
Q4 | $264K | Buy |
1,921
+134
| +7% | +$18.4K | 0.03% | 511 |
|
|
2024
Q3 | $267K | Sell |
1,787
-2,537
| -59% | -$379K | 0.03% | 518 |
|
|
2024
Q2 | $590K | Buy |
4,324
+2,708
| +168% | +$369K | 0.08% | 396 |
|
|
2024
Q1 | $244K | Hold |
1,616
| – | – | 0.03% | 520 |
|
|
2023
Q4 | $204K | Buy |
+1,616
| New | +$204K | 0.03% | 528 |
|
|
2023
Q1 | – | Sell |
-2,701
| Closed | -$330K | – | 500 |
|
|
2022
Q4 | $330K | Buy |
+2,701
| New | +$330K | 0.06% | 406 |
|